Comprehensive COVID-19 Slideset: Symptoms and Clinical Manifestations

Slideset updated regularly to include the latest data on the evolution and duration of COVID-19 symptoms and prevalence and duration of natural immunity.
Ada Adimora, MD, MPH
David Heymann, BA, MD, DTM&H
Arthur Kim, MD
Sharon R. Lewin, AO, FRACP, PhD, FAHMS
Jens D. Lundgren, MD, DMSc
Vikramjit Mukherjee, MD
Roger Paredes, MD, PhD
Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS
Format: Microsoft PowerPoint (.ppt)
File Size: 1.85 MB
Released: March 26, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by
Gilead Sciences, Inc.

Related Content

Clinical Care Options’ (CCO) commentary from Dr. Paul E. Sax on promising studies of a repurposed drug, fluvoxamine, for treatment of COVID-19

Paul E. Sax, MD Released: September 21, 2021

Clinical Care Options’ (CCO) commentary from Dr. Vikramjit Mukherjee on the association between surges in COVID-19 caseload and mortality.

Vikramjit Mukherjee, MD Released: September 3, 2021

Downloadable slides from CCO on the rationale and evidence supporting timeliness in the administration of therapies that act directly against SARS-CoV-2

Arthur Kim, MD Lynora Saxinger, MD, FRCPC, CTropMed Released: August 25, 2021

Concise Clinical Care Options (CCO) presentation by Arthur Kim, MD, on emerging oral antiviral options for outpatient treatment of SARS-CoV-2 infection

Arthur Kim, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: August 25, 2021 Expired: August 24, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue